Digital dermatitis, sole ulcer and white line disease standardized to the same currency, the same base year, and — where the literature allows it — the same units, so the three lesions can be read against each other rather than one at a time.
Figures below are each lesion's page midpoint — the average of the lowest and highest 2026 figure from a primary source that models cost bottom-up (treatment + milk + fertility + culling), not a treatment-only quote. See each lesion's own tab for the full source table and conversion method.
| Lesion | Low | High | Midpoint used in calculator | Cheapest primary source | Most expensive primary source |
|---|---|---|---|---|---|
| Digital Dermatitis | €120 | €160 | €140 | Willshire & Bell 2009 (€123) | Dolecheck 2018 sim., severe subtype (€250) |
| Sole Ulcer | €234 | €847 | €540 most expensive | Cha et al. 2010 (€234) | Willshire & Bell 2009 (€847) |
| White Line Disease | €257 | €685 | €470 | Charfeddine & Pérez-Cabal 2017, mild (€257) | Charfeddine & Pérez-Cabal 2017, severe (€685) |
Cha et al. 2010, the only US bottom-up dynamic-programming model in this literature, does not cover WLD at all — its absence is itself informative about which lesions get modeled. See the WLD tab, section 01.
No single study breaks down all three lesions into the same cost categories, so this composite blends what each does report: Cha et al. 2010's 3-part split for DD and SU, and Charfeddine & Pérez-Cabal 2017's 6-part severity split for SU and WLD (mild and severe averaged). Each lesion's category shares are then weighted by that lesion's typical annual cost contribution — case rate (Barker 2007) × cost per case — so the pie reflects a representative 100-cow herd, not three lesions of equal weight.
DD contributes no data to the non-saleable-milk and culling slices: Willshire & Bell 2009 records 0% added culling risk for DD, and Cha et al.'s DD model does not separate a withheld-milk component. This likely understates DD's true culling/withdrawal cost rather than proving it is zero.
The one dataset that scores all three lesions on the same cows and farms (Amory et al. 2008, 1,824 cows / 30 UK & Wales farms) is the cleanest head-to-head comparison available. DD shows no significant loss in that dataset; SU's loss is roughly 1.6× WLD's, and SU's decline is detectable ~3 months before diagnosis, while WLD's only appears from the month of diagnosis.
| Lesion | kg lost / lactation | 95% CI | Onset relative to diagnosis |
|---|---|---|---|
| Digital Dermatitis | not significant | — | slight rise immediately after treatment |
| Sole Ulcer | 574 largest | 307–841 kg | ~3 months before diagnosis |
| White Line Disease | 369 | 137–600 kg | from month of diagnosis |
This is the one measure where the ranking inverts: SU is the most expensive and costs the most milk, but in Huxley 2015's Ontario data (citing Cramer et al. 2009), it's WLD that carries the highest hazard ratio for culling at trimming.
| Lesion | Hazard ratio | Share of Willshire & Bell's total herd lameness cost |
|---|---|---|
| Digital Dermatitis | not reported in this study | 2% |
| Sole Ulcer | 1.26 2.4–2.7 in Booth et al. 2004 | 56% largest share |
| White Line Disease | 1.72 highest | 25% |
Booth et al. 2004 (a separate US model) puts SU's culling hazard much higher, at 2.4–2.7 — the two studies disagree on magnitude but agree that SU's culling risk is substantial. No comparable WLD figure exists in Booth et al., so the two lesions can only be compared hazard-ratio-to-hazard-ratio within a single study (Huxley/Cramer), not mixed across studies.
| Lesion | Defining feature | Where to look first |
|---|---|---|
| DD | Cheapest, weakest yield signal, but likely under-recorded — treated informally in the parlour/footbath and rarely logged | Treatment & fertility cost (composition, DD tab §02) |
| SU | Most expensive, largest milk loss, earliest-onset decline, largest herd-cost share | Milk yield findings (SU tab §03) |
| WLD | Mid-range cost, but the single highest culling hazard ratio recorded for any claw lesion | Fertility & culling (WLD tab §04) |
Published cost, milk-yield and fertility figures for DD in heifers and cows, drawn from the literature folder, standardized to euros and re-expressed in 2026 purchasing power. See the Overview tab for a side-by-side comparison against sole ulcer and white line disease.
Detailed findings tables and source citations below remain in English for scientific precision.
Three independent models — one UK, one US, one US stochastic simulation — land within a few euros of each other once standardized, despite using different data and years. That convergence is worth a slide on its own.
| Source | Country | Year | As published | EUR, year of study | 2026 value (today) |
|---|---|---|---|---|---|
| Willshire & Bell 2009 | UK | 2009 | £75.57 | €84.9 | €123 |
| Cha et al. 2010 | USA | 2010 | $132.96 | €100.4 | €144 |
| Dolecheck 2018 (simulation, mean) | USA | 2017† | $137 ± 36 | €121.5 | €159 |
| — mild subtype | USA | 2017† | $59 | €52.3 | €69 |
| — severe subtype | USA | 2017† | $215 | €190.6 | €250 |
| Charfeddine & Pérez-Cabal 2017 — mild | Spain | 2017† | $53 | €47.0 | €62 |
| Charfeddine & Pérez-Cabal 2017 — severe | Spain | 2017† | $402 | €356.4 | €467 |
| Bruijnis et al. 2010 per cow/yr | Netherlands | 2017† | $22 | €19.5 | €26 |
| Robcis et al. 2022 per cow/yr | France | 2022 | €391.80 ± 10.0 | €392 | €439 |
† Willshire & Bell (UK) and Cha et al. (US), Bruijnis et al. (Netherlands) and Charfeddine & Pérez-Cabal (Spain) figures were re-expressed by Dolecheck & Bewley (2018) in 2017 USD before we converted them back to EUR — treat the last three as order-of-magnitude, not precise, since they carry a currency round-trip.
| Component | Share | 2026 value equivalent |
|---|---|---|
| Treatment | 42% | €61 |
| Reduced fertility | 31% | €45 |
| Milk loss | 27% | €38 |
Unlike sole ulcer (milk loss dominates at 38%) or general lameness, DD's cost is driven by treatment and fertility, not yield — consistent with the milk-yield findings below.
Unlike sole ulcer or white line disease, DD's milk-yield signal is weak, inconsistent in direction, and often not significant — the literature does not support a large per-case yield loss for adult cows. Heifer-onset DD carried into first lactation is the exception.
| Source | Population | Effect |
|---|---|---|
| Willshire & Bell 2009 | UK herd model | 0 L — assumed no measurable loss (cites Warnick 2001, Amory 2008) |
| Amory et al. 2008 | 1,824 cows, 30 UK/Wales farms | No significant loss; slight rise immediately after treatment |
| Ettema et al. 2007 | Danish Holsteins, 1st lactation | −1.22 kg ECM/test-day if DD <101 DIM (sig.); non-significant or positive at later stages |
| Gomez et al. 2014/15 | US heifers, DD during rearing | −199 kg (1 DD event) / −335 kg (≥2 events) over first 305 DIM of 1st lactation |
| Randall et al. 2016 | UK heifers, DD 2–4mo post-calving | +2.63 kg/day raw effect, but −341 days in herd → net lifetime loss of 3,513 kg |
| Charfeddine & Pérez-Cabal 2017 (via Robcis 2022) | Spain | −21 kg/month active-stage DD (M1/M2/M4.1); −14 kg/month M3 |
| Source | Population | Effect |
|---|---|---|
| Willshire & Bell 2009 | UK herd model | +20 days to calving–conception interval (cites Argaez-Rodriguez 1997); 0% added culling risk (cites Booth 2004) |
| Gomez et al. 2014/15 | US heifers, ≥2 DD events in rearing | 13.3 pp lower first-service conception; +24 days open in 1st lactation |
| Charfeddine & Pérez-Cabal 2017 (via Dolecheck 2018) | Spain | No significant effect on length of productive life, unlike sole ulcer/WLD (−35 to −71 days) |
For scale: Willshire & Bell's own herd model puts DD's share of total lameness cost at just 2% (vs. 56% sole ulcer), and flags this as a likely underestimate given how often DD is treated informally in the parlour or footbath and never logged.
Published cost, milk-yield and fertility figures for sole ulcer (SU) in dairy cows, standardized to euros and re-expressed in 2026 purchasing power. See the Overview tab for a side-by-side comparison against digital dermatitis and white line disease.
Detailed findings tables and source citations below remain in English for scientific precision.
Sole ulcer is consistently the most expensive claw lesion in every model that compares lesion types side by side — it drives the largest share of both milk loss and culling risk.
| Source | Country | Year | As published | EUR, year of study | 2026 value (today) |
|---|---|---|---|---|---|
| Willshire & Bell 2009 | UK | 2009 | £518.73 | €583.1 | €847 |
| Cha et al. 2010 | USA | 2010 | $216.07 | €163.2 | €234 |
| Robcis et al. 2022 lit. range | mixed | mixed | €130–1,040/yr | — | not re-inflated† |
| Source | Country | As published (2017 USD) | EUR, 2017 | 2026 value (today) |
|---|---|---|---|---|
| Esslemont & Peeler 1993 | UK | $982/case | €870.5 | €1,140 |
| Kossaibati & Esslemont 1997 | UK | $1,073/cow affected | €951.2 | €1,246 |
| Esslemont 2005 | UK | $699/cow affected | €619.7 | €812 |
| Willshire & Bell 2009 cross-check | UK | $960/case | €850.9 | €1,115 |
| Cha et al. 2010 cross-check | USA | $243/case | €215.4 | €282 |
| Charfeddine & Pérez-Cabal 2017 — mild | Spain | $232/cow affected | €205.7 | €269 |
| Charfeddine & Pérez-Cabal 2017 — severe | Spain | $622/cow affected | €551.2 | €722 |
| Bruijnis et al. 2010 per cow/yr | Netherlands | $11/cow/year | €9.75 | €12.8 |
† Robcis et al.'s cited range pools studies spanning 1996–2019 without individual dates — shown as published, not inflation-adjusted. The two "cross-check" rows are Dolecheck & Bewley's own re-expression of Willshire & Bell and Cha et al.; compare against those studies' direct-conversion rows above — the gap (€1,115 vs €847; €282 vs €234) reflects Dolecheck's own conversion assumptions and is a reasonable measure of how much uncertainty a currency round-trip adds.
| Component | Share | 2026 value equivalent |
|---|---|---|
| Milk loss | 38% | €89 |
| Reduced fertility | 33% | €77 |
| Treatment | 28% | €66 |
| Component | Mild (€269) | Severe (€722) |
|---|---|---|
| Labor | €69 (25.5%) | €165 (22.9%) |
| Therapeutics | €39 (14.6%) | €85 (11.7%) |
| Non-saleable milk (withheld) | €0 (0%) | €146 (20.2%) |
| Reduced milk | €49 (18.3%) | €114 (15.8%) |
| Reproduction | €4 (1.5%) | €44 (6.1%) |
| Culling / death | €108 (40.2%) | €168 (23.3%) |
Culling risk dominates a mild case; once milk has to be discarded (withdrawal) and reproduction is affected, a severe case is driven by a broader spread of cost centres. SU's culling hazard ratio (2.4–2.7, Booth et al. 2004) is the highest of any lesion type studied.
SU shows roughly twice the milk loss of white line disease in the same UK dataset, and the decline is detectable weeks before the cow is actually diagnosed — suggesting the lesion is doing damage well before it's caught at trimming.
| Source | Population | Effect |
|---|---|---|
| Amory et al. 2008 | 230 SU cases, 30 UK/Wales farms | 574 kg/lactation loss (95% CI 307–841 kg); significant decline begins ~3 months before diagnosis, rising to 96 kg/month by 5+ months post |
| Cha et al. 2010 (model input) | US, Warnick et al. 2001 data | 1.07 kg/d (1st lactation); 2.40–2.91 kg/d (2nd lactation) — largest single cost component at €89/case |
| Warnick et al. 2001 | 2 US herds | Herd A: −2.5 kg/d at 2wk, −2.3 kg/d at 3+wk (significant); Herd B: non-significant, +0.8 kg/d — large herd-to-herd variability |
| Robcis et al. 2022 (Charfeddine data) | France/Spain model | −97 to −115 kg/month — the largest monthly loss of the three claw-horn lesions modeled |
| Randall et al. 2016 | UK heifers, sole lesion score ≥4 | −2.68 kg/d raw; net lifetime loss of 9,928 kg once 326 fewer days in herd are factored in — the largest lifetime figure of any lesion in this cohort |
| Ettema et al. 2007 | Danish Holsteins, primiparous | +0.59 kg ECM/test-day (95% CI 0.24–0.95) — positive association; SU tends to occur in higher-yielding cows |
| Source | Population | Effect |
|---|---|---|
| Willshire & Bell 2009 | UK herd model | +40 days to calving–conception interval (cites Collick et al. 1989); +56% culling risk — the highest of any lesion in this model |
| Cha et al. 2010 | US model | Conception odds ratio 0.52 vs. healthy; culling risk 1.41–1.70%/month; retention payoff at calving falls to $367 (average cow) / $236 (low-yield cow), bringing optimal culling forward from month 12 to month 6–9 |
| Booth et al. 2004 | US, hazard ratios | Culling HR 2.4–2.7 depending on diagnosis/exit window — the strongest culling association of any lesion this study modeled |
| Randall et al. 2016 | UK heifers | Future lameness risk OR 2.90 if sole lesion score ≥4 at 2–4 months post-calving; protective effect (OR 0.52 on culling) if diagnosed before calving |
| Huxley 2015 (cites Cramer et al. 2009) | Ontario | Culling hazard ratio 1.26 at trimming |
Willshire & Bell's herd model puts SU's share of total herd lameness cost at 56% — by far the largest single contributor, ahead of white line disease (25%) and digital dermatitis (2%).
Published cost, milk-yield and fertility figures for white line disease (WLD) in dairy cows, standardized to euros and re-expressed in 2026 purchasing power. See the Overview tab for a side-by-side comparison against digital dermatitis and sole ulcer.
Detailed findings tables and source citations below remain in English for scientific precision.
WLD sits consistently below sole ulcer on cost and milk loss, but above it on one measure: in the one study that scores culling hazard by lesion type, WLD carries the highest culling hazard ratio of any claw lesion.
| Source | Country | Year | As published | EUR, year of study | 2026 value (today) |
|---|---|---|---|---|---|
| Willshire & Bell 2009 | UK | 2009 | £300.05 | €337.3 | €490 |
| Cha et al. 2010 | not covered — the model only covers sole ulcer, digital dermatitis and foot rot | ||||
| Robcis et al. 2022 lit. range | mixed | mixed | €152–571/yr | — | not re-inflated† |
| Source | Country | As published (2017 USD) | EUR, 2017 | 2026 value (today) |
|---|---|---|---|---|
| Willshire & Bell 2009 cross-check | UK | $555/case | €491.9 | €644 |
| Charfeddine & Pérez-Cabal 2017 — mild | Spain | $221/cow affected | €195.9 | €257 |
| Charfeddine & Pérez-Cabal 2017 — severe | Spain | $590/cow affected | €523.0 | €685 |
† Robcis et al.'s cited range pools studies spanning 1996–2019 without individual dates — shown as published, not inflation-adjusted. The "cross-check" row is Dolecheck & Bewley's own re-expression of Willshire & Bell; the €644 vs €490 gap reflects Dolecheck's own conversion assumptions, a reasonable measure of the uncertainty a currency round-trip adds. No US-model figure exists for WLD, unlike sole ulcer and DD, since Cha et al. 2010 (the only bottom-up US dynamic-programming model in this literature) did not model it.
No US dynamic-programming breakdown exists for WLD (see above), so composition here comes only from Charfeddine & Pérez-Cabal's Spanish severity model.
| Component | Mild (€257) | Severe (€685) |
|---|---|---|
| Labor | €74 (28.7%) | €131 (19.1%) |
| Therapeutics | €42 (16.4%) | €79 (11.6%) |
| Non-saleable milk (withheld) | €0 (0%) | €138 (20.1%) |
| Reduced milk | €34 (13.4%) | €114 (16.6%) |
| Reproduction | €8 (3.0%) | €22 (3.2%) |
| Culling / death | €99 (38.5%) | €202 (29.5%) |
Mild WLD has the highest labor share of any lesion/severity combination in this model (28.7%) — consistent with WLD being a fiddly, time-consuming lesion to pare out even when the case itself is minor.
In the one dataset that scores both lesions on the same cows and farms (Amory et al. 2008), WLD's milk loss is about 64% of sole ulcer's, and the production decline only becomes visible around the time of diagnosis rather than months before it.
| Source | Population | Effect |
|---|---|---|
| Amory et al. 2008 | 169 WLD cases, 30 UK/Wales farms | 369 kg/lactation loss (95% CI 137–600 kg) — roughly half sole ulcer's 574 kg; decline only becomes significant from the month of diagnosis, rising to 90 kg/month by 5 months post |
| Robcis et al. 2022 (Charfeddine data) | France/Spain model | −48 to −90 kg/month — consistently smaller than sole ulcer's −97 to −115 kg/month in the same model |
| Ettema et al. 2007 | Danish Holsteins | No significant effect at any lactation stage (estimates −0.25 to −0.82 kg ECM, all CIs cross zero); could not be separated from sole ulcer/heel horn erosion for multiparous cows due to low case counts |
| Randall et al. 2016 | UK heifers | No significant milk-yield effect detected for white-line lesions in this cohort, unlike sole lesions in the same study |
| Source | Population | Effect |
|---|---|---|
| Willshire & Bell 2009 | UK herd model | +30 days to calving–conception interval (cites Lucey et al. 1986); +11% culling risk — but this figure is borrowed from the generic "digital lameness" category, not independently sourced for WLD‡ |
| Huxley 2015 (cites Cramer et al. 2009) | Ontario | Culling hazard ratio 1.72 at trimming — the highest of any lesion type in that study, above sole ulcer (1.26) and sole haemorrhage (1.36) |
| Randall et al. 2016 | UK heifers | Future lameness risk OR 3.48 if white-line lesion score ≥3 at 2–4 months post-calving; protective effect (OR 0.34) if scored 2–4 before calving; no significant effect on milk yield or overall culling in the main models |
‡ Willshire & Bell's herd model puts WLD's share of total herd lameness cost at 25% — the second-largest contributor after sole ulcer (56%), well ahead of digital dermatitis (2%).
Enter this year's case counts for digital dermatitis, sole ulcer and white line disease. Cost-per-case defaults come from the published literature, standardized to 2026 euros — edit them if you have better local numbers. Use the currency selector at the top to view totals in USD or GBP; the editable assumptions below always stay in euros.
Based on Barker 2007 (cited in Willshire & Bell 2009): DD 1.7, SU 7.2, WLD 5.6 cases per 100 cows per year. Your own trim records will always beat a national average.
Midpoint of €120–160 — three independent 2026-adjusted models (UK, US, US simulation) converge here.
Midpoint of €234–847 — US bottom-up model vs. UK herd model, 2026-adjusted. Consistently the most expensive lesion in the literature.
Midpoint of €257–685 — UK model vs. mild/severe Spanish model, 2026-adjusted.
Each lesion's total is split into treatment/labor, milk loss, withheld milk, reproduction and culling using the same composition data as the Overview tab, applied to this herd's actual case mix.
How to read this: these are literature averages (Willshire & Bell 2009, Cha et al. 2010, Charfeddine & Pérez-Cabal 2017, standardized to 2026 euros), not this farm's actual costs — treat the total as an order-of-magnitude estimate for prioritizing which lesion to tackle first, not an invoice. Swap in your own treatment and milk costs under "Cost-per-case assumptions" if you have them.